laitimes

Jichuan Pharmaceutical: Pudilan anti-inflammatory oral liquid, a wholly-owned subsidiary, withdrew from the provincial medical insurance directory

author:Straight Flush Finance

Jichuan Pharmaceutical (600566): The main variety of Pudilan anti-inflammatory oral liquid of Jichuan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary, will withdraw from the "Catalogue of Drugs for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in Shandong Province" on November 1, 2021. In 2020, the sales amount of Pudilan anti-inflammatory oral liquid in Shandong Province was about 164 million yuan.

Read on